Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-083563
Filing Date
2023-07-24
Accepted
2023-07-24 21:04:34
Documents
2
Period of Report
2023-07-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2321918-6_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2321918-6_3seq1.xml 3 1564
2 EXHIBIT 24 tm2321918d6_ex24.htm EX-24 9965
  Complete submission text file 0001104659-23-083563.txt   13006
Mailing Address C/O RXSIGHT, INC. 100 COLUMBIA ALISO VIEJO CA 92656
Business Address
Thunen Shelley B (Reporting) CIK: 0001297491 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40021 | Film No.: 231106257

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations